{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:50:27Z","timestamp":1773809427069,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Endomagnetics Ltd"},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sentinel lymph node (SLN) status is pivotal for treatment decision-making in patients with breast cancer. Superparamagnetic iron oxide nanoparticles (SPIO) have been shown to be equivalent to the dual technique with technetium<jats:sup>99m<\/jats:sup> (Tc<jats:sup>99<\/jats:sup>) and blue dye (BD) for SLN detection. The aim of this study was to determine the feasibility of detecting SLNs using an ultra-low dose of SPIO.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Patients planned for breast conserving surgery and SLN biopsy were included. An intradermal injection of 0.1 mL SPIO was administered at the areolar border up to 7 days before surgery. Tc<jats:sup>99<\/jats:sup>\/BD was administered according to clinical routine. SLNs were detected during surgery using a handheld magnetometer. All nodes with a magnetic and\/or radioactive signal, as well as blue or clinically suspicious nodes, were harvested and analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 50 patients, SPIO was injected a median of 4 days before surgery. At least one SLN was found in all patients with both methods. A total of 98 SLNs were removed; 90 were detected using SPIO and 88 using Tc<jats:sup>99<\/jats:sup>\/BD. Of the 90 SLNs detected by SPIO, 80 were Tc<jats:sup>99<\/jats:sup>\/BD positive (concordance 89%). Histopathological analysis classified 16 patients with tumor cells deposit and 9 with macro-metastasis &gt; 2mm, where one SLN was identified only by the radioactive technique and one only by the magnetic technique.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>SLN detection using 0.1 mL ultra-low dose SPIO injected intradermally was successful in all patients. A future analysis will determine whether the approach using an ultra-low dose of SPIO injected intradermally will minimize skin staining and MRI artefacts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-023-13722-x","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:02:10Z","timestamp":1686747730000},"page":"5685-5689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ultra-Low Dose of Superparamagnetic Iron Oxide Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer"],"prefix":"10.1245","volume":"30","author":[{"given":"Nushin","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"W\u00e4rnberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontus","family":"Zaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Leonhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-0355","authenticated-orcid":false,"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"issue":"17","key":"13722_CR1","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u0142awek A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel). 2021;13(17):4287.","journal-title":"Cancers (Basel)."},{"issue":"5\u20136","key":"13722_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10585-018-9908-8","volume":"35","author":"CM Balch","year":"2018","unstructured":"Balch CM. Detection of melanoma metastases with the sentinel node biopsy: the legacy of Donald L. Morton, MD (1934\u20132014). Clin Exp Metastasis. 2018;35(5\u20136):425\u20139.","journal-title":"Clin Exp Metastasis."},{"issue":"22","key":"13722_CR3","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1088\/0031-9155\/61\/22\/8120","volume":"61","author":"S Waanders","year":"2016","unstructured":"Waanders S, Visscher M, Wildeboer RR, Oderkerk TO, Krooshoop HJ, Ten Haken B. A handheld SPIO-based sentinel lymph node mapping device using differential magnetometry. Phys Med Biol. 2016;61(22):8120\u201334.","journal-title":"Phys Med Biol."},{"issue":"12","key":"13722_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/bjs.10606","volume":"104","author":"A Karakatsanis","year":"2017","unstructured":"Karakatsanis A, Daskalakis K, St\u00e5lberg P, et al. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer. Br J Surg. 2017;104(12):1675\u201385.","journal-title":"Br J Surg."},{"issue":"2","key":"13722_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10549-016-3809-9","volume":"157","author":"A Karakatsanis","year":"2016","unstructured":"Karakatsanis A, Christiansen PM, Fischer L, et al. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies. Breast Cancer Res Treat. 2016;157(2):281\u201394.","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"13722_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejso.2021.12.467","volume":"48","author":"N Mirzaei","year":"2022","unstructured":"Mirzaei N, Katsarelias D, Zaar P, et al. Sentinel lymph node localization and staging with a low-dose of superparamagnetic iron oxide (SPIO) enhanced MRI and magnetometer in patients with cutaneous melanoma of the extremity: the MAGMEN feasibility study. Eur J Surg Oncol. 2022;48(2):326\u201332.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"13722_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejso.2014.11.006","volume":"41","author":"IT Rubio","year":"2015","unstructured":"Rubio IT, Diaz-Botero S, Esgueva A, et al. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol. 2015;41(1):46\u201351.","journal-title":"Eur J Surg Oncol."},{"issue":"12","key":"13722_CR8","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.ejso.2020.06.018","volume":"46","author":"IT Rubio","year":"2020","unstructured":"Rubio IT, Rodriguez-Revuelto R, Espinosa-Bravo M, Siso C, Rivero J, Esgueva A. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: the SUNRISE study. Eur J Surg Oncol. 2020;46(12):2195\u2013201.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"13722_CR9","doi-asserted-by":"publisher","first-page":"e12385","DOI":"10.1111\/ecc.12385","volume":"26","author":"M Ghilli","year":"2017","unstructured":"Ghilli M, Carretta E, Di Filippo F, et al. The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment. Eur J Cancer Care (Engl). 2017;26(4):e12385.","journal-title":"Eur J Cancer Care (Engl)."},{"issue":"4","key":"13722_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/cancers13040693","volume":"13","author":"AF Hersi","year":"2021","unstructured":"Hersi AF, Pistiolis L, Dussan Luberth C, et al. Optimizing dose and timing in magnetic tracer techniques for sentinel lymph node detection in early breast cancers: the prospective multicenter SentiDose trial. Cancers (Basel). 2021;13(4):693.","journal-title":"Cancers (Basel)."},{"issue":"12","key":"13722_CR11","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1245\/s10434-011-1710-7","volume":"18","author":"K Motomura","year":"2011","unstructured":"Motomura K, Ishitobi M, Komoike Y, et al. SPIO-enhanced magnetic resonance imaging for the detection of metastases in sentinel nodes localized by computed tomography lymphography in patients with breast cancer. Ann Surg Oncol. 2011;18(12):3422\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"13722_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/bjs.10040","volume":"103","author":"K Motomura","year":"2016","unstructured":"Motomura K, Izumi T, Tateishi S, et al. Superparamagnetic iron oxide-enhanced MRI at 3 T for accurate axillary staging in breast cancer. Br J Surg. 2016;103(1):60\u20139.","journal-title":"Br J Surg."},{"issue":"11","key":"13722_CR13","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1093\/bjs\/znab277","volume":"108","author":"K Motomura","year":"2021","unstructured":"Motomura K, Tabuchi Y, Enomoto Y, et al. Accurate axillary staging by superparamagnetic iron oxide-enhanced MRI at 1.5 T with fat-suppression sequence as an alternative to sentinel node biopsy in breast cancer. Br J Surg. 2021;108(11):e359\u201360.","journal-title":"Br J Surg."},{"issue":"1","key":"13722_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jmri.10134","volume":"16","author":"C Stets","year":"2002","unstructured":"Stets C, Brandt S, Wallis F, Buchmann J, Gilbert FJ, Heywang-K\u00f6brunner SH. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. JMRI. 2002;16(1):60\u20138.","journal-title":"JMRI."},{"key":"13722_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clinimag.2020.12.011","volume":"75","author":"E Aribal","year":"2021","unstructured":"Aribal E, \u00c7elik L, Yilmaz C, Demirkiran C, Guner DC. Effects of iron oxide particles on MRI and mammography in breast cancer patients after a sentinel lymph node biopsy with paramagnetic tracers. Clin Imaging. 2021;75:22\u20136.","journal-title":"Clin Imaging."},{"issue":"3","key":"13722_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5152\/ejbh.2019.4410","volume":"15","author":"G Arslan","year":"2019","unstructured":"Arslan G, Yilmaz C, Celik L, Cubuk R, Tasali N. Unexpected finding on mammography and MRI due to accumulation of iron oxide particles used for sentinel lymph node detection. Eur J Breast Health. 2019;15(3):200\u20132.","journal-title":"Eur J Breast Health."},{"issue":"5","key":"13722_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ejso.2018.01.241","volume":"44","author":"A Karakatsanis","year":"2018","unstructured":"Karakatsanis A, Obondo C, Abdsaleh S, Hersi AF, Eriksson S, W\u00e4rnberg F. Optimisation of breast MRI compatibility after sentinel node biopsy with paramagnetic tracers. Eur J Surg Oncol. 2018;44(5):731\u20132.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"13722_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejso.2017.11.016","volume":"44","author":"B Krischer","year":"2018","unstructured":"Krischer B, Forte S, Niemann T, Kubik-Huch RA, Leo C. Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers. Eur J Surg Oncol. 2018;44(1):74\u20139.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"13722_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.breast.2014.01.004","volume":"23","author":"M Thill","year":"2014","unstructured":"Thill M, Kurylcio A, Welter R, et al. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast. 2014;23(2):175\u20139.","journal-title":"Breast."},{"issue":"4","key":"13722_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/bjs5.50157","volume":"3","author":"CW Mok","year":"2019","unstructured":"Mok CW, Tan SM, Zheng Q, Shi L. Network meta-analysis of novel and conventional sentinel lymph node biopsy techniques in breast cancer. BJS Open. 2019;3(4):445\u201352.","journal-title":"BJS Open."},{"issue":"11","key":"13722_CR21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/bjs.10283","volume":"103","author":"A Zada","year":"2016","unstructured":"Zada A, Peek MC, Ahmed M, et al. Meta-analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique. Br J Surg. 2016;103(11):1409\u201319.","journal-title":"Br J Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13722-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13722-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13722-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T13:11:02Z","timestamp":1691500262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13722-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["13722"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13722-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}